Sona is co-founder and CEO of Neopenda, a global health startup using technology to reduce newborn mortality in low-resource settings. Sona’s path to global health entrepreneurship began when she earned a BS in Chemical Engineering from Georgia Tech (2011), and subsequently worked as an engineer in Bioprocess Research and Development at Eli Lilly and Company. She followed her passion for service to Kenya, spending time as a teacher and a Engineering Without Borders volunteer. Sona’s interest in aiding under-resourced communities continued during her research involvement with mChip, a point-of-care diagnostic device for HIV and syphilis developed at Columbia University. She also worked at the TB Alliance, both in community engagement and drug discovery for medications that treat tuberculosis. Sona completed a Masters in Biomedical Engineering at Columbia University (2016) before launching Neopenda, where she develops works to develop impactful healthcare solutions, and sustainably deliver them to the world’s most vulnerable populations.